Zobrazeno 1 - 10
of 16
pro vyhledávání: ''
Autor:
Mercedes Delgado-García, Enrique de Alava, Michele Biscuola, Mar Varela, Xavier Matias-Guiu, Ernest Nadal, Ángela María Blanco, Lourdes Gómez-Izquierdo, Ana Alarcão, Bélgica Márquez-Lobo, María José Hernández, Birgit Weynand
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Repositorio Abierto de la UdL
Universitad de Lleida
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Recercat. Dipósit de la Recerca de Catalunya
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Universidad de Barcelona
Repositorio Abierto de la UdL
Universitad de Lleida
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Recercat. Dipósit de la Recerca de Catalunya
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
[Background] Detection of epidermal growth factor receptor (EGFR) mutations in exons 18–21 is recommended in all patients with advanced Non-small-cell lung carcinoma due to the demonstrated efficiency of the standard therapy with tyrosine kinase in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee0fb381a07cab4bbb80b03ec364759
http://hdl.handle.net/2445/173079
http://hdl.handle.net/2445/173079
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Background In this prospective non-interventional study, the effectiveness and tolerability of erlotinib in elderly patients with non-small-cell lung cancer (NSCLC) after ≥1 platinum-based chemotherapy were assessed. Methods A total of 385 patients
Autor:
Albert Sánchez-Font, Mercè Mateu-Jimenez, Joaquim Gea, Rafael Aguiló, Lara Pijuan, Víctor Curull, Alberto Rodríguez-Fuster, Esther Barreiro
Publikováno v:
Clinical Epigenetics
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-11 (2018)
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-11 (2018)
Background Chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and epigenetic events underlie lung cancer (LC) development. The study objective was that lung tumor expression levels of specific microRNAs and their downstream bi
Autor:
Akira Iyoda, Keigo Takagi, Kazuma Kishi, Yoshinobu Hata, Takefumi Nakayama, Makoto Nagashima, Mitsutaka Kadokura, Yuichi Ozeki, Hajime Otsuka, Yoshitaka Murakami, Shingo Ikeda, Takaharu Kiribayashi
Publikováno v:
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Background We conducted a multicenter randomized study of adjuvant S-1 administration schedules for surgically treated pathological stage IB-IIIA non-small cell lung cancer patients. Methods Patients receiving curative surgical resection were central
Autor:
Ge Wang, Yu-Xi Zhu, Zhi-Hua Ruan, Zhimin Zhang, Xiao He, Guo-Dong Liu, Hua-Liang Xiao, Hao He, Bo Zhu, Zhenzhou Yang, Mengxia Li, Rong-Qing Li, Bao-Hua Lan, Yan Wu
Publikováno v:
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Background Central nervous system (CNS) brain metastasis of advanced non-small cell lung cancer (NSCLC) patients confers a worse quality of life and prognosis. The efficacy comparison of two first-generation epidermal growth factor receptor (EGFR) in
Publikováno v:
BMC Cancer
Background The screening of ROS proto-oncogene 1, receptor tyrosine kinase(ROS1) fusion rearrangement might be potentially beneficial for an effective therapy against non-small cell lung cancer (NSCLC). However, the three main ROS1 rearrangement dete
Autor:
Jiemin Cormier, Elie Fadel, Olaf Mercier, Benjamin Besse, Philippe Dartevelle, Emilie Louvet, Thierry Lebret, Vincent Thomas de Montpréville, Christian Auclair, Ken A. Olaussen, Julien Adam, Soly Fattal, Angélique Robin, Aicha Goubar, Mathieu Rouanne, Caroline Ohana, Jean-Charles Soria, Peter Dorfmüller
Publikováno v:
BMC Cancer
Background Osteopontin (OPN) and thrombospondin-1 (TSP-1) are extracellular matrix proteins secreted by stromal and tumor cells. These proteins appear to have a key role in the tumor microenvironment for cancer development and metastasis. There is li
Autor:
Jennifer S. Smith, You-Lin Qiao, Stephen E. Hawes, James P. Hughes, Joseph J. Carter, Danny V. Colombara, Denise A. Galloway, Noel S. Weiss, Philip R. Taylor, Lisa E. Manhart
Publikováno v:
BMC Cancer
Background Studies of human polyomavirus (HPyV) infection and lung cancer are limited and those regarding the association of human papillomavirus (HPV) infection and lung cancer have produced inconsistent results. Methods We conducted a nested case
Autor:
Yun Jung Kim, Young Jin Kim, Dong Jin Im, Hyo Sup Shim, Jae Seok Lee, Sae Rom Hong, Jin Hur, Byoung Wook Choi, Young-Joo Suh, Yong Wha Moon, Hye Jeong Lee, Arthur Cho, Joo Hang Kim, Yoo Jin Hong
Publikováno v:
BMC Cancer
BMC CANCER(16)
BMC CANCER(16)
Background: EGFR mutation-induced cell proliferation causes changes in tumor biology and tumor metabolism, which may reflect tumor marker concentration and 18F-FDG uptake on PET/CT. Direct aspirates of primary lung tumors contain different concentrat
Autor:
Gunhild Mari Mælandsmo, Marius Lund-Iversen, Odd Terje Brustugun, Gisle Berge, Ane Kongsgaard Rud, Steinar Solberg, Kjetil Boye
Publikováno v:
BMC Cancer
BMC Cancer, Vol 12, Iss 1, p 333 (2012)
BMC Cancer, Vol 12, Iss 1, p 333 (2012)
Background The metastasis-promoting protein S100A4 induces expression of ephrin-A1 and osteopontin in osteosarcoma cell lines. The aim of this study was to investigate S100A4-mediated stimulation of ephrin-A1 and osteopontin in non-small cell lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a092b13bf9d82b3221739ac6a36bee
https://hdl.handle.net/10037/4903
https://hdl.handle.net/10037/4903